Welcome To The Mannkind HUB On AGORACOM
Edit this title from the Fast Facts Section
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

AGORACOM News Flash

BREAKING NEWS!!!

Marijuana Company of America Launches HempSmart Brand and Begins Manufacturing Its First Proprietary CBD Brain Health Product

  • First HempSmart branded CBD based product called “HempSmart BRAIN,” has entered manufacturing process;
  • Formulated to promote brain health;
  • Combines nootropic benefits with the additional benefits offered by CBD;
  • Shipments expected by September 30, 2016

15233_mcoa

Hub On AGORACOM / Read Release

----------------------------------

VGambling Inc. Partners With Income Access

  • Announced agreement with Income Access, a technology and digital marketing company serving the global iGaming industry
  • Company will integrate Income Access’ award-winning affiliate management platform and Ad Serving tool to manage the operator’s forthcoming affiliate programme

Vgabmlinglarge_copy

Hub On AGORACOM / Read Release

Message: MannKind Corporation to Present at The 31st Annual J.P. Morgan Healthcare Confer

Barney-fife-crop-fix
Rank: [?]
President
Points: [?]
5496
Rating: [?]
Votes: 21 Score: 4.5
  • Currently 4.5/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

MannKind Corporation to Present at The 31st Annual J.P. Morgan Healthcare Confer

posted on Jan 03, 13 05:39PM

MannKind Corporation to Present at The 31st Annual J.P. Morgan Healthcare Conference

VALENCIA, Calif.
BusinessWire

MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at The 31st Annual J.P. Morgan Healthcare Conference on Thursday, January 10, 2013 at 8:00 AM (PST) at St. Francis Hotel in San Francisco, California.

Interested parties can access a link to the live webcast of the presentations from the News & Events section of the Company's website at http://www.mannkindcorp.com.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. Its lead product candidate, AFREZZA®, is in late stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. MannKind maintains a website at www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.

Contacts

MannKind Corporation
Matthew J. Pfeffer
Corporate Vice President and
Chief Financial Officer
661-775-5300 begin_of_the_skype_highlighting 661-775-5300 end_of_the_skype_highlighting
mpfeffer@mannkindcorp.com

© Copyright (c) Business Wire

http://www.vancouversun.com/mobile/business/businesswire/MannKind+Corporation+Present+31st+Annual+Morgan+Healthcare+Conference/7772440/story.html

New Message

Please login to post a reply

AGORACOM Quick Tips

Small & Micro Cap 2.0 Blog by George Tsiolis ... Read it Now

President's D.D.

Here's the latest Griffin report read more

Stock Quote

Hub Leaders